A detailed history of Picton Mahoney Asset Management transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 5,883 shares of VYGR stock, worth $21,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,883
Holding current value
$21,472
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Apr 02, 2025

BUY
$5.27 - $8.07 $31,003 - $47,475
5,883 New
5,883 $33,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $141M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Picton Mahoney Asset Management Portfolio

Follow Picton Mahoney Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Picton Mahoney Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Picton Mahoney Asset Management with notifications on news.